UK Stocks Trading Below Estimated Value

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties. In such a fluctuating environment, identifying undervalued stocks can be crucial for investors seeking opportunities that may offer potential value despite broader market pressures.

Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom

Name	Current Price	Fair Value (Est)	Discount (Est)
Playtech (LSE:PTEC)	£4.046	£7.50	46%
Pan African Resources (LSE:PAF)	£1.383	£2.60	46.9%
On the Beach Group (LSE:OTB)	£1.94	£3.71	47.7%
Next 15 Group (AIM:NFG)	£3.17	£6.31	49.7%
Kistos Holdings (AIM:KIST)	£2.75	£5.28	47.9%
Eurocell (LSE:ECEL)	£1.215	£2.26	46.3%
Entain (LSE:ENT)	£5.11	£9.83	48%
Diaceutics (AIM:DXRX)	£1.435	£2.85	49.6%
Convatec Group (LSE:CTEC)	£2.296	£4.25	46%
Atalaya Mining Copper (LSE:ATYM)	£11.00	£20.85	47.2%

Click here to see the full list of 47 stocks from our Undervalued UK Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

AdvancedAdvT (AIM:ADVT)

Overview: AdvancedAdvT Limited provides software solutions and platforms across Europe, the United Kingdom, North America, and internationally, with a market cap of £237.62 million.

Operations: The company's revenue is primarily derived from its Internet Software & Services segment, which generated £53.40 million.

Estimated Discount To Fair Value: 18.1%

AdvancedAdvT is trading at £1.8, below its estimated future cash flow value of £2.2, representing an 18.1% discount to fair value. Despite lower profit margins compared to last year, earnings are expected to grow significantly at 32% annually over the next three years, outpacing the UK market's forecasted growth rate of 11.5%. However, revenue growth is projected at a modest 5% per year with large one-off items impacting financial results.

• In light of our recent growth report, it seems possible that AdvancedAdvT's financial performance will exceed current levels.
• Dive into the specifics of AdvancedAdvT here with our thorough financial health report.

Advanced Medical Solutions Group (AIM:AMS)

Overview: Advanced Medical Solutions Group plc develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets across several regions including the UK, Germany, France, Europe, and the US with a market cap of £610.29 million.

Operations: The company's revenue is primarily derived from its surgical segment, which accounts for £183.45 million, and its woundcare segment, contributing £45.49 million.

Estimated Discount To Fair Value: 45.1%

Advanced Medical Solutions Group is trading at £2.82, significantly below its estimated future cash flow value of £5.12, indicating a substantial undervaluation. The company anticipates revenue growth to reach approximately £115.2 million for the first half of 2026, despite some shipping delays and de-stocking impacts. Earnings are forecasted to grow at a robust 39.8% annually over the next three years, surpassing UK market expectations, although Return on Equity remains relatively low at 13.8%.

• Our expertly prepared growth report on Advanced Medical Solutions Group implies its future financial outlook may be stronger than recent results.
• Click to explore a detailed breakdown of our findings in Advanced Medical Solutions Group's balance sheet health report.

Applied Nutrition (LSE:APN)

Overview: Applied Nutrition Plc is involved in the manufacture, wholesale, and retail of sports nutritional products both in the United Kingdom and internationally, with a market cap of £793.75 million.

Operations: The company generates revenue of £134 million from its segment focused on the manufacture and sale of sports nutrition products.

Estimated Discount To Fair Value: 13.4%

Applied Nutrition's current trading price of £3.18 is below its estimated future cash flow value of £3.67, reflecting a potential undervaluation based on cash flows. The company reported significant revenue growth to £160 million for the year ended July 31, 2026, with expectations to reach approximately £205 million by July 2027. Despite substantial insider selling recently, earnings are forecasted to grow at a steady rate of 11.9% annually, outpacing the UK market average growth rate.

• The analysis detailed in our Applied Nutrition growth report hints at robust future financial performance.
• Navigate through the intricacies of Applied Nutrition with our comprehensive financial health report here.

Taking Advantage

• Discover the full array of 47 Undervalued UK Stocks Based On Cash Flows right here.
• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com